ANI Pharmaceuticals Inc (ANIP)
Financial leverage ratio
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total assets | US$ in thousands | 1,283,700 | 1,287,380 | 920,753 | 914,524 | 904,422 | 889,914 | 859,341 | 765,224 | 760,087 | 739,110 | 751,334 | 744,846 | 771,598 | 470,454 | 480,159 | 463,843 | 461,190 | 462,581 | 465,391 | 482,232 |
Total stockholders’ equity | US$ in thousands | 428,530 | 430,798 | 455,760 | 451,963 | 432,749 | 454,711 | 434,472 | 339,482 | 338,540 | 336,675 | 336,958 | 346,094 | 358,740 | 191,403 | 191,917 | 203,712 | 195,700 | 195,100 | 191,344 | 201,171 |
Financial leverage ratio | 3.00 | 2.99 | 2.02 | 2.02 | 2.09 | 1.96 | 1.98 | 2.25 | 2.25 | 2.20 | 2.23 | 2.15 | 2.15 | 2.46 | 2.50 | 2.28 | 2.36 | 2.37 | 2.43 | 2.40 |
December 31, 2024 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $1,283,700K ÷ $428,530K
= 3.00
The financial leverage ratio of ANI Pharmaceuticals Inc has shown some fluctuations over the years based on the provided data. The ratio measures the company's use of debt to finance its operations and indicates the proportion of debt in its capital structure.
From March 31, 2020, to June 30, 2020, the financial leverage ratio increased slightly from 2.40 to 2.43 before decreasing to 2.37 by September 30, 2020. There was a further decrease to 2.36 by December 31, 2020. The ratio then continued to decline steadily over the next few quarters, reaching its lowest point of 1.96 as of September 30, 2023.
However, starting from December 31, 2023, the financial leverage ratio began to increase again, rising to 2.09 by the end of that quarter and further to 2.02 by March 31, 2024, and June 30, 2024. The ratio then jumped significantly to 2.99 by September 30, 2024, and remained high at 3.00 by December 31, 2024.
Overall, the trend in the financial leverage ratio of ANI Pharmaceuticals Inc indicates periods of fluctuation and volatility in the company's capital structure, with varying levels of debt utilization over the years. Investors and stakeholders may want to closely monitor these changes to assess the company's risk exposure and financial stability.
Peer comparison
Dec 31, 2024